244 related articles for article (PubMed ID: 14734604)
41. Interaction of the NK cell inhibitory receptor Ly49A with H-2Dd: identification of a site distinct from the TCR site.
Natarajan K; Boyd LF; Schuck P; Yokoyama WM; Eliat D; Margulies DH
Immunity; 1999 Nov; 11(5):591-601. PubMed ID: 10591184
[TBL] [Abstract][Full Text] [Related]
42. MHC class I-Ly49 interactions shape the Ly49 repertoire on murine NK cells.
Fahlén L; Lendahl U; Sentman CL
J Immunol; 2001 Jun; 166(11):6585-92. PubMed ID: 11359811
[TBL] [Abstract][Full Text] [Related]
43. Critical residues at the Ly49 natural killer receptor's homodimer interface determine functional recognition of m157, a mouse cytomegalovirus MHC class I-like protein.
Kielczewska A; Kim HS; Lanier LL; Dimasi N; Vidal SM
J Immunol; 2007 Jan; 178(1):369-77. PubMed ID: 17182575
[TBL] [Abstract][Full Text] [Related]
44. Class I MHC-binding characteristics of the 129/J Ly49 repertoire.
Makrigiannis AP; Pau AT; Saleh A; Winkler-Pickett R; Ortaldo JR; Anderson SK
J Immunol; 2001 Apr; 166(8):5034-43. PubMed ID: 11290784
[TBL] [Abstract][Full Text] [Related]
45. Ly-49P activates NK-mediated lysis by recognizing H-2Dd.
Silver ET; Gong DE; Chang CS; Amrani A; Santamaria P; Kane KP
J Immunol; 2000 Aug; 165(4):1771-81. PubMed ID: 10925254
[TBL] [Abstract][Full Text] [Related]
46. NKG2D receptor-mediated NK cell function is regulated by inhibitory Ly49 receptors.
Regunathan J; Chen Y; Wang D; Malarkannan S
Blood; 2005 Jan; 105(1):233-40. PubMed ID: 15328154
[TBL] [Abstract][Full Text] [Related]
47. Mouse Ly-49D recognizes H-2Dd and activates natural killer cell cytotoxicity.
Nakamura MC; Linnemeyer PA; Niemi EC; Mason LH; Ortaldo JR; Ryan JC; Seaman WE
J Exp Med; 1999 Feb; 189(3):493-500. PubMed ID: 9927511
[TBL] [Abstract][Full Text] [Related]
48. Alpha1/alpha2 domains of H-2D(d), but not H-2L(d), induce "missing self" reactivity in vivo--no effect of H-2L(d) on protection against NK cells expressing the inhibitory receptor Ly49G2.
Johansson MH; Höglund E; Nakamura MC; Ryan JC; Höglund P
Eur J Immunol; 1998 Dec; 28(12):4198-206. PubMed ID: 9862356
[TBL] [Abstract][Full Text] [Related]
49. Structural basis of MHC class I recognition by natural killer cell receptors.
Sawicki MW; Dimasi N; Natarajan K; Wang J; Margulies DH; Mariuzza RA
Immunol Rev; 2001 Jun; 181():52-65. PubMed ID: 11513152
[TBL] [Abstract][Full Text] [Related]
50. Ly49A expression on T cells alters T cell selection.
Fahlén L; Oberg L; Brännström T; Khoo NK; Lendahl U; Sentman CL
Int Immunol; 2000 Feb; 12(2):215-22. PubMed ID: 10653857
[TBL] [Abstract][Full Text] [Related]
51. MHC class I recognition by Ly49 natural killer cell receptors.
Natarajan K; Dimasi N; Wang J; Margulies DH; Mariuzza RA
Mol Immunol; 2002 May; 38(14):1023-7. PubMed ID: 11955594
[TBL] [Abstract][Full Text] [Related]
52. Transgenic expression of Ly49A on T cells impairs a specific antitumor response.
Brawand P; Lemonnier FA; MacDonald HR; Cerottini JC; Held W
J Immunol; 2000 Aug; 165(4):1871-6. PubMed ID: 10925266
[TBL] [Abstract][Full Text] [Related]
53. Visualization of inhibitory Ly49 receptor specificity with soluble major histocompatibility complex class I tetramers.
Michaëlsson J; Achour A; Salcedo M; Kâse-Sjöström A; Sundbäck J; Harris RA; Kärre K
Eur J Immunol; 2000 Jan; 30(1):300-7. PubMed ID: 10602053
[TBL] [Abstract][Full Text] [Related]
54. Location-specific regulation of transgenic Ly49A receptors by major histocompatibility complex class I molecules.
Fahlén L; Khoo NK; Daws MR; Sentman CL
Eur J Immunol; 1997 Aug; 27(8):2057-65. PubMed ID: 9295045
[TBL] [Abstract][Full Text] [Related]
55. A "chimeric" C57l-derived Ly49 inhibitory receptor resembling the Ly49D activation receptor.
Mehta IK; Smith HR; Wang J; Margulies DH; Yokoyama WM
Cell Immunol; 2001 Apr; 209(1):29-41. PubMed ID: 11414734
[TBL] [Abstract][Full Text] [Related]
56. Receptor/ligand avidity determines the capacity of Ly49 inhibitory receptors to interfere with T-cell receptor-mediated activation.
Chalifour A; Roger J; Lemieux S; Duplay P
Immunology; 2003 May; 109(1):58-67. PubMed ID: 12709018
[TBL] [Abstract][Full Text] [Related]
57. Immunoreceptor tyrosine-based inhibitory motif-dependent functions of an MHC class I-specific NK cell receptor.
Bern MD; Beckman DL; Ebihara T; Taffner SM; Poursine-Laurent J; White JM; Yokoyama WM
Proc Natl Acad Sci U S A; 2017 Oct; 114(40):E8440-E8447. PubMed ID: 28923946
[TBL] [Abstract][Full Text] [Related]
58. NK cell receptor calibration: effects of MHC class I induction on killing by Ly49Ahigh and Ly49Alow NK cells.
Olsson-Alheim MY; Salcedo M; Ljunggren HG; Kärre K; Sentman CL
J Immunol; 1997 Oct; 159(7):3189-94. PubMed ID: 9317116
[TBL] [Abstract][Full Text] [Related]
59. Transgenic expression of the Ly49A natural killer cell receptor confers class I major histocompatibility complex (MHC)-specific inhibition and prevents bone marrow allograft rejection.
Held W; Cado D; Raulet DH
J Exp Med; 1996 Nov; 184(5):2037-41. PubMed ID: 8920892
[TBL] [Abstract][Full Text] [Related]
60. Epitope mapping of Ly-49G and G-like receptors: CK-1 antibody defines a polymorphic site of functional interaction with class I ligand.
Osman MS; Silver ET; Varghese JC; Chang CS; Gong DE; Audette GF; Hazes B; Kane KP
J Leukoc Biol; 2005 May; 77(5):644-51. PubMed ID: 15703200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
